PURE Bioscience (PURE) Stock Analysis & Winston Score

PURE Bioscience makes cleaning and disinfecting products using a silver-based technology called SILV-X. The company sells antimicrobial solutions to schools, food service companies, and healthcare facilities that need to kill germs without harsh chemicals. It operates in the consumer defensive sector, competing against much larger cleaning product brands.

The company earns money by selling its disinfectant products and licensing its silver dioxide technology to other businesses. PURE Bioscience is a small company based in California, with most of its sales coming from the United States. Its main competitive edge is the patented silver-based formula, which it claims is effective against a broad range of pathogens without leaving toxic residue — but the biggest risk is its ongoing operating losses, meaning it spends more money than it brings in, and it will need to significantly grow revenue or cut costs to reach profitability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+13.6% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+1.4% YoY

YoY Growth Rate

Slow EPS growth

Insider Activity

30.6%ownership

↓ Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~1 months

$198,000 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

PURE Bioscience has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

53.6%

Healthy — 53.6% gross margin

Operating Margin

-153.8%

Losing money on operations — -153.8%

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+7.2%

Steady sales growth (7.2% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-101.3%

Burning cash (-101.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial